Use the collections feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
Harish Ravipati, Nishank P Nooli, Charles W Hoopes, Enrique Gongora, Britt McILwain, Charles M Tyndal, Erik J Orozco-Hernandez
Peripheral extracorporeal membrane oxygenation (ECMO) is one of the most common strategies for cardiogenic shock. ECMO cannulation is associated with an increased risk of complications. We describe a minimally invasive, off-pump technique to provide adequate hemodynamic support and left ventricular unloading. A 54-year-old male with nonischemic cardiomyopathy and severe peripheral vascular disease with cardiogenic shock was initially supported with inotropes and an intra-aortic balloon pump. Despite continued support, he continued to deteriorate, and we escalated to a temporary left ventricular support with a CentriMag, using a transapical ProtekDuo Rapid Deployment cannula via mini left-thoracotomy...
June 2023: Journal of Surgical Case Reports
#2
JOURNAL ARTICLE
Raquel López-Vilella, Ignacio Sánchez-Lázaro, Azucena Pajares Moncho, Mónica Talavera Peregrina, Manuel Pérez Guillén, Iratxe Zarragoikoetxea Jáuregui, Ricardo Gimeno Costa, Víctor Donoso Trenado, Luis Martínez Dolz, Salvador Torregrosa Puerta, Luis Almenar Bonet
BACKGROUND: The purpose of this study was to compare early and late survival among patients who have undergone heart transplantation (HTx) with a short-term mechanical assist device. METHODS: This was an ambispective, single-center, consecutive study of patients undergoing urgent HTx for 5 years. Pediatric transplants, retransplants, and combined transplants were excluded. Forty-five patients were included. Four groups were analyzed: those with venoarterial extracorporeal membrane oxygenation (ECMO) implanted <10 days before HTx; those with ECMO implanted for >10 days; patients classified as INTERMACS 2 to 3 with Levitronix Centrimag implanted; and those classified as INTERMACS 2 with Levitronix Centrimag implanted...
November 2021: Transplantation Proceedings
#3
JOURNAL ARTICLE
M Kawabori, A C Critsinelis, T Nordan, F Y Chen, A Vest, M S Kiernan, D DeNofrio, G S Couper
PURPOSE: Preoptimizing the hemodynamics and volume status prior to heart transplant is essential for the outcome. Temporary mechanical circulatory support (MCS) has been expanding especially after recent changes to the UNOS donor heart allocation criteria. The aim of our study is to evaluate the incidence of various MCS device use and outcomes of preoperative MCS to heart transplantation. METHODS: We performed a retrospective analysis using the UNOS Resistry of all adult heart transplant recipients from 1997 to 2017 comparing various MCS device regarding days to discharge, hospital survival and 2 year survival rates...
April 2020: Journal of Heart and Lung Transplantation
#4
JOURNAL ARTICLE
Ulrich P Jorde, Omar Saeed, Devin Koehl, Alanna A Morris, Katherine L Wood, Dan M Meyer, Ryan Cantor, Jeffrey P Jacobs, James K Kirklin, Francis D Pagani, J David Vega
The 14th Annual Report from The Society of Thoracic Surgeons (STS) Interagency Registry for Mechanically Assisted Circulatory Support (Intermacs) describes outcomes of 27,493 patients with a continuous-flow left ventricular assist device (LVAD) from the past decade (2013-2022). In 2022, 2517 primary LVADs were implanted, of which 2512 (99.8%) were fully magnetically levitated (Mag-Lev) devices. This shift to nearly exclusive use of a Mag-Lev device led us to examine its outcomes compared with contemporary (2018-2022) and historical (2013-2017) non-Mag-Lev cohorts...
January 2024: Annals of Thoracic Surgery
#5
JOURNAL ARTICLE
Alexander M Bernhardt, Evgenij Potapov, Christophe Vandenbriele, Carsten Skurk, Letizia F Bertoldi, Federico Pappalardo
Cardiogenic shock (CS) is a life-threatening condition characterized by a state of inadequate systemic tissue perfusion caused by cardiac dysfunction. When to implement, change, or remove the use of a temporary mechanical circulatory support (tMCS) in patients with CS is dependent on the aetiology and severity. Here, patient scenarios underlying the need to escalate, de-escalate, wean, or bridge from tMCS devices are taken into consideration by interdisciplinary heart failure and CS teams. This includes a comprehensive review of and focus on the rationale for specific device escalation and de-escalation strategies, device selection, and general management...
December 2023: European Heart Journal Supplements: Journal of the European Society of Cardiology
#6
JOURNAL ARTICLE
Naoki Tadokoro, Kohei Tonai, Satoshi Kainuma, Satsuki Fukushima
The combination of the Impella and peripheral venoarterial extracorporeal membrane oxygenation (Ecmella) is a promising treatment for critically ill patients. We report a single access Ecmella approach using the brachiocephalic artery. A 65-year-old woman with acute myocardial infarction involving the left main coronary artery underwent intra-aortic balloon pump and peripheral venoarterial extracorporeal membrane oxygenation (VA-ECMO) placement. Given the progression of pulmonary congestion and lower limb ischaemia, and an axillary artery diameter of 4...
December 13, 2023: Interdiscip Cardiovasc Thorac Surg
#7
REVIEW
Shriya Sharma, Jose Ruiz, Smit Paghdar, Smruti Desai, Rohan Goswami
BACKGROUND: Pulmonary arterial hypertension (PAH) is characterized by persistently increased pressure in the pulmonary arteries. New defining criteria for the different hemodynamic types of pulmonary hypertension (PH) that occur with left heart disease have been proposed by the task force on PH. After consideration of the changes in the general definition of PH in left heart disease, the proposed hemodynamic definition was: (1) isolated postcapillary PH: pulmonary artery wedge pressure >15 mm Hg and mean pulmonary arterial pressure (mPAP) >20 mm Hg and pulmonary vascular resistance (PVR) <3 Woods units (WU); and (2) combined post- and precapillary PH: pulmonary artery wedge pressure >15 mm Hg, mPAP >20 mm Hg, and PVR ≥3 WU...
December 2023: Transplantation Proceedings
#8
JOURNAL ARTICLE
Matthew R Carey, Dylan Marshall, Kevin Clerkin, Ronald Laracuente, Joseph Sanchez, Sneha S Jain, Jayant K Raikhelkar, Jay S Leb, Yuji Kaku, Melana Yuzefpolskaya, Yoshifumi Naka, Paolo C Colombo, Gabriel T Sayer, Koji Takeda, Nir Uriel, Veli K Topkara, Justin A Fried
BACKGROUND: Aortic root thrombosis(ART) is a complication of continuous-flow left ventricular assist device therapy. However, the incidence and related complications of ART in HeartMate 3 (HM3) patients remain unknown. METHODS: Patients who underwent HM3 implantation from November 2014 to August 2020 at a quaternary academic medical center were included. Demographics and outcomes were abstracted from the medical record. Echocardiograms and contrast-enhanced computed tomography studies were reviewed to identify patients who developed ART and/or moderate or greater aortic insufficiency (AI) on HM3 support...
September 20, 2023: Journal of Heart and Lung Transplantation
#9
JOURNAL ARTICLE
Diyar Saeed, David Feldman, Aly El Banayosy, Emma Birks, Elizabeth Blume, Jennifer Cowger, Christopher Hayward, Ulrich Jorde, Jamila Kremer, Guy MacGowan, Simon Maltais, Simon Maybaum, Mandeep Mehra, Keyur B Shah, Paul Mohacsi, Martin Schweiger, Sarah E Schroeder, Palak Shah, Marvin Slepian, Laurens F Tops, Paulino Alvarez, Francisco Arabia, Saima Aslam, Louis Benson-Louis, Edo Birati, Holger W Buchholz, Ari Cedars, Dawn Christensen, Agnieszka Ciarka, Erin Coglianese, Rebecca Cogswell, Jennifer Cook, Jack Copeland, Jose Gonzalez Costello, Stavros G Drakos, Pirooz Eghtesady, Tonya Elliot, Jerry D Estep, Jaime-Juergen Eulert-Grehn, De Rita Fabrizio, Jens Garbade, Jill Gelow, Maya Guglin, Jaime Hernandez-Montfort, Doug Horstmanshof, Ranjit John, Manreet Kanwar, Feras Khaliel, Gene Kim, Sachin Kumar, Jacob Lavee, Marzia Leache, Pascal Leprince, Sern Lim, Antonio Loforte, Jiri Maly, Samer Najjar, Ivan Netuka, Salpy V Pamboukian, Snehal R Patel, Sean Pinney, Christina Vander Pluym, Evgenij Potapov, Desiree Robson, Yogita Rochlani, Stuart Russell, Kristin Sandau, Elena Sandoval, Gabriel Sayer, Sarah Schettle, David Schibilsky, Thomas Schlöglhofer, Jan Schmitto, Aleem Siddique, Scott Silvestry, Mark S Slaughter, Benjamin Sun, Hiroo Takayama, Ryan Tedford, Jeffrey J Teuteberg, Van-Khue Ton, Nir Uriel, Juliane Vierecke, Daniel Zimpfer, David D'Alessandro
No abstract text is available yet for this article.
July 2023: Journal of Heart and Lung Transplantation
#10
JOURNAL ARTICLE
William G Cohen, David Rekhtman, Amit Iyengar, Max Shin, Michael Ibrahim, Christian Bermudez, Marisa Cevasco, Joyce Wald
We report midterm results of Impella 5.5 use with focus placed on bridge-outcomes, venoarterial extracorporeal membrane oxygenation (VA-ECMO) transition, complications, and risk factors for mortality. A retrospective review of patients implanted with the Impella 5.5 at our medical center was conducted. Forty patients were included with varying bridge strategies. Sixteen (40%) patients were supported for <14 days, 13 (32.5%) for 14-30 days, and 11 (27.5%) for >30 days. Thirty day mortality was 22.5% (9/40)...
July 1, 2023: ASAIO Journal: a Peer-reviewed Journal of the American Society for Artificial Internal Organs
#11
JOURNAL ARTICLE
Daniel Lewin, Gaik Nersesian, Pia Lanmüller, Felix Schoenrath, Volkmar Falk, Evgenij V Potapov, Sascha Ott
BACKGROUND: Impella 5.0 and 5.5 (summarized as Impella 5+) are microaxial, catheter-based left ventricular assist devices (LVAD) that are implanted via a vascular graft sutured to the axillary artery and provide blood flow of up to 5.5 liter/min. This study aims to investigate the incidence of long-term complications following circulatory support with Impella 5+. METHODS: A single-center retrospective analysis of 203 consecutive adult patients treated between January 2017 and September 2021 with a surgically implanted Impella 5...
May 2023: Journal of Heart and Lung Transplantation
#12
JOURNAL ARTICLE
Anubodh S Varshney, David D Berg, Guohai Zhou, Lauren Sinnenberg, Sameer Hirji, Ersilia M DeFilippis, Hari R Mallidi, David A Morrow, Daniel Rinewalt, Michael M Givertz
AIMS: To describe outcomes associated with bridging strategies in patients with acute decompensated heart failure-related cardiogenic shock (ADHF-CS) bridged to durable left ventricular assist device (LVAD) or heart transplantation (HTx). METHODS AND RESULTS: Durable LVAD or HTx recipients from 2014 to 2019 with pre-operative ADHF-CS were identified in the Society of Thoracic Surgeons Adult Cardiac Surgery Database and stratified by bridging strategy. The primary outcome was operative or 30-day post-operative mortality...
March 2023: European Journal of Heart Failure
#13
JOURNAL ARTICLE
Mazen F Odish, Robert L Owens, Cassia Yi, Eugene Golts, Travis Pollema
No abstract text is available yet for this article.
December 21, 2022: ASAIO Journal: a Peer-reviewed Journal of the American Society for Artificial Internal Organs
#14
COMPARATIVE STUDY
Koji Takeda, Arthur R Garan, Masahiko Ando, Jiho Han, Veli K Topkara, Paul Kurlansky, Melana Yuzefpolskaya, Maryjane A Farr, Paolo C Colombo, Yoshifumi Naka, Hiroo Takayama
OBJECTIVES: We recently developed a novel minimally invasive surgical approach that combines extracorporeal membrane oxygenation and CentriMag ventricular assist device (Ec-VAD) for the treatment of cardiogenic shock as a short-term circulatory support. We compared the outcomes of this new approach to conventional CentriMag biventricular assist device (BiVAD) support through a median sternotomy. METHODS: Between July 2015 and August 2016, 22 patients were implanted with CentriMag Ec-VAD and 90 patients were implanted with conventional CentriMag BiVAD...
December 1, 2017: European Journal of Cardio-thoracic Surgery
#15
JOURNAL ARTICLE
Eduardo Barge-Caballero, Francisco González-Vílchez, Luis Almenar-Bonet, María Dolores García-Cosío Carmena, José González-Costello, Manuel Gómez-Bueno, María Ángeles Castel-Lavilla, José Luis Lambert-Rodríguez, Manuel Martínez-Sellés, Sonia Mirabet-Pérez, Luis De la Fuente-Galán, Daniela Hervás-Sotomayor, Diego Rangel-Sousa, Iris P Garrido-Bravo, Teresa Blasco-Peiró, Gregorio Rábago Juan-Aracil, Javier Muñiz, María G Crespo-Leiro
BACKGROUND: We aimed to describe recent trends in the use and outcomes of temporary mechanical circulatory support (MCS) as a bridge to heart transplantation (HTx) in Spain. METHODS: Retrospective case-by-case analysis of 1,036 patients listed for emergency HTx while on temporary MCS in 16 Spanish institutions from January 1st, 2010 to December 31st, 2020. Patients were classified in 3 eras according to changes in donor allocation criteria (Era 1: January 2010/May 2014; Era 2: June 2014/May 2017; Era 3: June 2017/December 2020)...
November 9, 2022: Journal of Heart and Lung Transplantation
#16
JOURNAL ARTICLE
Richard W Walsh, Nathan J Smith, John F Shepherd, Mia S Turbati, Bi Qing Teng, Ruta Brazauskas, David L Joyce, Lyle D Joyce, Lucian Durham, Peter J Rossi
BACKGROUND: Mechanical circulatory support effectively treats adult cardiogenic shock. Whereas cardiogenic shock confers high mortality, acute limb ischemia is a known complication of mechanical circulatory support that confers significant morbidity. We compared our novel approach to peripheral mechanical circulatory support with a conventional femoral approach, with a focus on the incidence of acute limb ischemia. METHODS: This was a retrospective cohort study of patients treated with mechanical circulatory support between January 1, 2015 and December 5, 2021 at our institution...
November 23, 2022: Surgery
#17
MULTICENTER STUDY
Deborah M F van den Buijs, Adriaan Wilgenhof, Paul Knaapen, Carlo Zivelonghi, Tom Meijers, Paul Vermeersch, Fatih Arslan, Niels Verouden, Alex Nap, Krischan Sjauw, Floris S van den Brink
OBJECTIVES: To compare two different forms of mechanical circulatory support (MCS) in patients with complex high-risk indicated PCI (CHIP): the Impella CP system and veno-arterial extracorporeal membrane oxygenation (VA-ECMO). BACKGROUND: To prevent hemodynamic instability in CHIP, various MCS systems are available. However, comparable data on different forms of MCS are not at hand. METHODS: In this multicenter observational study, we retrospectively evaluated all CHIP procedures with the support of an Impella CP or VA-ECMO, who were declined surgery by the heart team...
2022: Journal of Interventional Cardiology
#18
JOURNAL ARTICLE
Waiel Abusnina, Mahmoud Ismayl, Ahmad Al-Abdouh, Vaishnavi Ganesan, Mostafa Reda Mostafa, Osama Hallak, Emily Peterson, Mahmoud Abdou, Andrew M Goldsweig, Ahmed Aboeata, Khagendra Dahal
Background: Cardiogenic shock (CS) carries high mortality. The roles of specific mechanical circulatory support (MCS) systems are unclear. We compared the clinical outcomes of Impella versus extracorporal membrane oxygenation (ECMO) in patients with CS. Methods: This is a systematic review and meta-analysis that was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta Analyses guidelines. We searched PubMed, Cochrane Central Register, Embase, Web of Science, Google Scholar, and ClinicalTrials...
November 1, 2022: Shock
#19
JOURNAL ARTICLE
Morgan A Hill, Jennie H Kwon, Khaled Shorbaji, Arman Kilic
BACKGROUND: Impella devices are increasingly utilized as a bridge to heart transplantation (BTT) and are now prioritized as Status 2 under the current heart allocation policy. This study evaluated waitlist and post-transplant outcomes of patients supported with Impella 5.0/5.5 devices. METHODS: The United Network of Organ Sharing registry was used to identify adults waitlisted or transplanted with Impella 5.0 or 5.5 devices from 2010 to 2021. Separate analyses were performed for waitlist and transplantation outcomes for patients supported by Impella 5...
December 2022: Journal of Cardiac Surgery
#20
JOURNAL ARTICLE
Lydia McDermott, Gary Cook, Joshua Park, Qiong Yang, Hitoshi Hirose
Leg ischemia is a potential complication of percutaneous left ventricular assist device (Impella CP®) placement. To avoid leg ischemia in at-risk patients, a distal perfusion catheter (DPC) should be placed. In utilizing a passive distal perfusion system from the contralateral femoral artery, we optimized blood flow to the distal limb mitigating leg ischemia. A 65-year-old female with dilated cardiomyopathy complicated by hemodynamic instability was placed on an Impella CP via the right femoral artery...
October 2022: Curēus
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
